Changes

Jump to navigation Jump to search
no edit summary
Line 22: Line 22:  
|
 
|
 
*↑SVR, ↑MAP
 
*↑SVR, ↑MAP
*Decreased insulin release, inhibits lipolysis, decreases aqueous humor production
+
*↓insulin release, ↓lipolysis, ↓aqueous humor production
 
|
 
|
presynaptic G<sub>i</sub> &rarr; &darr;AC &rarr; &darr;cAMP &rarr; inhibition of NT release, sympatholytic effects
+
presynaptic G<sub>i</sub> &rarr; &darr;AC &rarr; &darr;cAMP &rarr; &darr;NT release, sympatholytic effects
 
|  
 
|  
 
*Dexmedetomidine
 
*Dexmedetomidine
Line 36: Line 36:  
| &beta;1 || Iso > NE > Epi
 
| &beta;1 || Iso > NE > Epi
 
|
 
|
*&uarr;Chronotropy (myocytes), &uarr;Inotropy (SA node) &rarr;&uarr;CO
+
*&uarr;Chronotropy (myocytes), &uarr;Inotropy (SA node), &uarr;SBP
 
*&uarr;Renin release/&uarr;volume (JGA)
 
*&uarr;Renin release/&uarr;volume (JGA)
 
*Amylase secretion
 
*Amylase secretion
Line 51: Line 51:  
*Esmolol
 
*Esmolol
 
|-
 
|-
| &beta;2 || Iso > Epi > NE || Smooth muscle relaxation || Gs, cAMP up
+
| &beta;2 || Iso > Epi > NE
 +
|
 +
*Smooth muscle relaxation, &darr;SVR, &darr;DBP, &darr;MAP
 +
*Bronchodilation
 +
*&uarr;Lipolysis, &uarr;Insulin release
 +
*Relax uterine smooth muscle
 +
*&uarr;aqueous humor production
 +
|
 +
G<sub>s</sub> &rarr; &uarr;cAMP &rarr; &uarr;PKA
 
|
 
|
 
*Albuterol
 
*Albuterol

Navigation menu